home / stock / axnx / axnx news

AXNX News and Press, Axonics Modulation Technologies Inc. From 08/01/19

Stock Information
Company Name: Axonics Modulation Technologies Inc.
Stock Symbol: AXNX
Market: NASDAQ
Website: axonics.com
Menu
AXNX AXNX Quote AXNX Short AXNX News AXNX Articles AXNX Message Board
Get AXNX Alerts

News, Short Squeeze, Breakout and More Instantly...
AXNX - Axonics® Announces 1-Year Top-Line Clinical Results from its ARTISAN-SNM Pivotal Study

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction , today announced completion of 1-year follo...
AXNX - Axonics® Announces Publication of ARTISAN Clinical Study Results in the Journal of Urology

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction , today announced the results from i...

AXNX - Axonics® to Report 2019 Second Quarter and Six-Month Financial Results and Host a Conference Call on August 5

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction , today announced that it will re...

AXNX - Axonics® Announces U.S. Food & Drug Administration Approves Use of Full-Body MRI for Pivotal Study Patients

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable sacral neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today announced the U....
AXNX - The Best-Performing Small-Cap Stocks YTD: May 2019

The iShares Russell 2000 ETF ( IWM ) tracks a basket of small-cap stocks including companies not typically part of large-cap broad market indexes like the S&P 500. Year to date, the ETF is up 15%, but still 10% below its all-time high set in August of 2018, which is in contrast to the S&am...

AXNX - Axonics Modulation Technologies' (AXNX) CEO Ray Cohen on Q1 2019 Results - Earnings Call Transcript

Axonics Modulation Technologies, Inc. (AXNX) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Jill Bertotti – W2O Group Ray Cohen – Chief Executive Officer Dan Dearen – President and Chief Financial Officer Conference Call Parti...

AXNX - CNDT, ROKU, STMP, and CTRL among midday movers

Gainers:  Control4 Corporation (NASDAQ: CTRL ) +39% . Roku (NASDAQ: ROKU ) +25% . TechTarget (NASDAQ: TTGT ) +20% . ShockWave Medical (NASDAQ: SWAV ) +19% . Dynavax Technologies (NASDAQ: DVAX ) +18% . Axonics Modulation Technologies (NASDAQ: AXNX ) +17% . Matrix Service Company ...
AXNX - Axonics Modulation Technologies misses by $0.13, beats on revenue

Axonics Modulation Technologies (NASDAQ: AXNX ): Q1 GAAP EPS of -$0.47 misses by $0.13 . More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

AXNX - Axonics® Announces First Quarter 2019 Financial Results and Operational Update

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, reported today financial results ...

AXNX - Axonics® Announces ARTISAN-SNM Pivotal Study Results Presented at the American Urological Association Annual Meeting

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , announced the presenta...
Previous 10 Next 10